Most common side effects were gastrointestinal, with 24.5% of participants in the phase 2 obesity trial discontinuing efinopegdutide 10 mg due to AE however when the same dose was used with gradual escalation at the MASLD trial (starting dose 2.4 mg for 4 weeks, then 5 mg for 4 weeks and then 10 mg), only 5.6% of participants discontinued the medication due to AE
Abnormalities in tests of copper metabolism in primary sclerosing cholangitis
Clothes may fit differently, and you might notice improved digestion or reduced bloating
Individual results vary based on starting weight, insulin resistance, sleep, stress, food quality, and consistency with follow up
GLP-1 receptor agonists caused dose-dependent thyroid C-cell tumors in rodent studies
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with flexible dosing, and the Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment